Sonara Health Granted Patent For Take-Home Methadone Monitoring System
DALLAS, Sept. 20, 2022 /PRNewswire/ -- Sonara Health has been granted a U.S. patent for creating a tamper-evident label that facilitates the safe consumption of methadone at home to treat opioid use disorder and fight America's opioid crisis.
- Revolutionary Monitoring System's Tamper-Evident Label Allows People To More Safely Consume Methadone From Home, Eliminating Daily Clinic Visits
DALLAS, Sept. 20, 2022 /PRNewswire/ -- Sonara Health has been granted a U.S. patent for creating a tamper-evident label that facilitates the safe consumption of methadone at home to treat opioid use disorder and fight America's opioid crisis. - Sonara Health's remote medication monitoring system includes a tamper-evident label, a patient-facing web application to guide the patient's daily consumption of methadone at home and a clinician-facing web application to remotely, asynchronously, observe patients dosing.
- The Sonara remote medication monitoring system helps eliminate the need for patients to visit a clinic every day, which is often a barrier for people who live far away from clinics or who have jobs and family obligations.
- The Sonara medication monitoring system is simple.